img

Global Nucleic Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nucleic Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A nucleic vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.
Nucleic Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nucleic Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nucleic Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nucleic Vaccine key manufacturers include Moderna, CureVac, Inovio, Sanofi, GSK, CNBG, Hualan Bio, Zhifei Shengwu and Liaoning Chengda, etc. Moderna, CureVac, Inovio are top 3 players and held % sales share in total in 2022.
Nucleic Vaccine can be divided into Preventive Nucleic Vaccine and Therapeutic Nucleic Vaccine, etc. Preventive Nucleic Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Nucleic Vaccine is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Nucleic Vaccine industry development. In 2022, global % sales of Nucleic Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nucleic Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
Segment by Type
Preventive Nucleic Vaccine
Therapeutic Nucleic Vaccine

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nucleic Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nucleic Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nucleic Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Nucleic Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nucleic Vaccine introduction, etc. Nucleic Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Nucleic Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Nucleic Vaccine Market Overview
1.1 Nucleic Vaccine Product Overview
1.2 Nucleic Vaccine Market Segment by Type
1.2.1 Preventive Nucleic Vaccine
1.2.2 Therapeutic Nucleic Vaccine
1.3 Global Nucleic Vaccine Market Size by Type
1.3.1 Global Nucleic Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Nucleic Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Nucleic Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nucleic Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Nucleic Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Nucleic Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Type (2024-2024)
2 Global Nucleic Vaccine Market Competition by Company
2.1 Global Top Players by Nucleic Vaccine Sales (2024-2024)
2.2 Global Top Players by Nucleic Vaccine Revenue (2024-2024)
2.3 Global Top Players by Nucleic Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Nucleic Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nucleic Vaccine Market Competitive Situation and Trends
2.5.1 Nucleic Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nucleic Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Nucleic Vaccine Market
2.8 Key Manufacturers Nucleic Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nucleic Vaccine Status and Outlook by Region
3.1 Global Nucleic Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Nucleic Vaccine Historic Market Size by Region
3.2.1 Global Nucleic Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Nucleic Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Nucleic Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Nucleic Vaccine Forecasted Market Size by Region
3.3.1 Global Nucleic Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Nucleic Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Nucleic Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Nucleic Vaccine by Application
4.1 Nucleic Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Nucleic Vaccine Market Size by Application
4.2.1 Global Nucleic Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Nucleic Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Nucleic Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nucleic Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Nucleic Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Nucleic Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Nucleic Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Nucleic Vaccine Sales Breakdown by Application (2024-2024)
5 North America Nucleic Vaccine by Country
5.1 North America Nucleic Vaccine Historic Market Size by Country
5.1.1 North America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Nucleic Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Nucleic Vaccine Sales in Value by Country (2024-2024)
5.2 North America Nucleic Vaccine Forecasted Market Size by Country
5.2.1 North America Nucleic Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Nucleic Vaccine Sales in Value by Country (2024-2034)
6 Europe Nucleic Vaccine by Country
6.1 Europe Nucleic Vaccine Historic Market Size by Country
6.1.1 Europe Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Nucleic Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Nucleic Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Nucleic Vaccine Forecasted Market Size by Country
6.2.1 Europe Nucleic Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Nucleic Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Nucleic Vaccine by Region
7.1 Asia-Pacific Nucleic Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Nucleic Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Nucleic Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Nucleic Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Nucleic Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Nucleic Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Nucleic Vaccine Sales in Value by Region (2024-2034)
8 Latin America Nucleic Vaccine by Country
8.1 Latin America Nucleic Vaccine Historic Market Size by Country
8.1.1 Latin America Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Nucleic Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Nucleic Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Nucleic Vaccine Forecasted Market Size by Country
8.2.1 Latin America Nucleic Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Nucleic Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Nucleic Vaccine by Country
9.1 Middle East and Africa Nucleic Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Nucleic Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Nucleic Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Nucleic Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Nucleic Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Nucleic Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Nucleic Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Moderna
10.1.1 Moderna Company Information
10.1.2 Moderna Introduction and Business Overview
10.1.3 Moderna Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Moderna Nucleic Vaccine Products Offered
10.1.5 Moderna Recent Development
10.2 CureVac
10.2.1 CureVac Company Information
10.2.2 CureVac Introduction and Business Overview
10.2.3 CureVac Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 CureVac Nucleic Vaccine Products Offered
10.2.5 CureVac Recent Development
10.3 Inovio
10.3.1 Inovio Company Information
10.3.2 Inovio Introduction and Business Overview
10.3.3 Inovio Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Inovio Nucleic Vaccine Products Offered
10.3.5 Inovio Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sanofi Nucleic Vaccine Products Offered
10.4.5 Sanofi Recent Development
10.5 GSK
10.5.1 GSK Company Information
10.5.2 GSK Introduction and Business Overview
10.5.3 GSK Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 GSK Nucleic Vaccine Products Offered
10.5.5 GSK Recent Development
10.6 CNBG
10.6.1 CNBG Company Information
10.6.2 CNBG Introduction and Business Overview
10.6.3 CNBG Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 CNBG Nucleic Vaccine Products Offered
10.6.5 CNBG Recent Development
10.7 Hualan Bio
10.7.1 Hualan Bio Company Information
10.7.2 Hualan Bio Introduction and Business Overview
10.7.3 Hualan Bio Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Hualan Bio Nucleic Vaccine Products Offered
10.7.5 Hualan Bio Recent Development
10.8 Zhifei Shengwu
10.8.1 Zhifei Shengwu Company Information
10.8.2 Zhifei Shengwu Introduction and Business Overview
10.8.3 Zhifei Shengwu Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Zhifei Shengwu Nucleic Vaccine Products Offered
10.8.5 Zhifei Shengwu Recent Development
10.9 Liaoning Chengda
10.9.1 Liaoning Chengda Company Information
10.9.2 Liaoning Chengda Introduction and Business Overview
10.9.3 Liaoning Chengda Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Liaoning Chengda Nucleic Vaccine Products Offered
10.9.5 Liaoning Chengda Recent Development
10.10 BioKangtai
10.10.1 BioKangtai Company Information
10.10.2 BioKangtai Introduction and Business Overview
10.10.3 BioKangtai Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 BioKangtai Nucleic Vaccine Products Offered
10.10.5 BioKangtai Recent Development
10.11 CanSinoBIO
10.11.1 CanSinoBIO Company Information
10.11.2 CanSinoBIO Introduction and Business Overview
10.11.3 CanSinoBIO Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 CanSinoBIO Nucleic Vaccine Products Offered
10.11.5 CanSinoBIO Recent Development
10.12 Walvax Biotechnology
10.12.1 Walvax Biotechnology Company Information
10.12.2 Walvax Biotechnology Introduction and Business Overview
10.12.3 Walvax Biotechnology Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Walvax Biotechnology Nucleic Vaccine Products Offered
10.12.5 Walvax Biotechnology Recent Development
10.13 Fosun Pharma
10.13.1 Fosun Pharma Company Information
10.13.2 Fosun Pharma Introduction and Business Overview
10.13.3 Fosun Pharma Nucleic Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Fosun Pharma Nucleic Vaccine Products Offered
10.13.5 Fosun Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nucleic Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nucleic Vaccine Industrial Chain Analysis
11.4 Nucleic Vaccine Market Dynamics
11.4.1 Nucleic Vaccine Industry Trends
11.4.2 Nucleic Vaccine Market Drivers
11.4.3 Nucleic Vaccine Market Challenges
11.4.4 Nucleic Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nucleic Vaccine Distributors
12.3 Nucleic Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Preventive Nucleic Vaccine
Table 2. Major Company of Therapeutic Nucleic Vaccine
Table 3. Global Nucleic Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Nucleic Vaccine Sales by Type (2024-2024) & (K Units)
Table 5. Global Nucleic Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Nucleic Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Nucleic Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Nucleic Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Nucleic Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Nucleic Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Nucleic Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Nucleic Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Nucleic Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Nucleic Vaccine Sales by Type (2024-2024) & (K Units)
Table 15. North America Nucleic Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Nucleic Vaccine Sales (K Units) by Type (2024-2024)
Table 17. Europe Nucleic Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Nucleic Vaccine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Nucleic Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Nucleic Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Nucleic Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Nucleic Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Nucleic Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Nucleic Vaccine Sales by Company (2024-2024) & (K Units)
Table 25. Global Nucleic Vaccine Sales Share by Company (2024-2024)
Table 26. Global Nucleic Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Nucleic Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Nucleic Vaccine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Nucleic Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Nucleic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Nucleic Vaccine Market
Table 33. Key Manufacturers Nucleic Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nucleic Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Nucleic Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Global Nucleic Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Nucleic Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Nucleic Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Nucleic Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Nucleic Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Nucleic Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Nucleic Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Nucleic Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Nucleic Vaccine Sales by Application (2024-2024) & (K Units)
Table 48. Global Nucleic Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Nucleic Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Nucleic Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Nucleic Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Nucleic Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. Global Nucleic Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Nucleic Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Nucleic Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Nucleic Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Nucleic Vaccine Sales by Application (2024-2024) (K Units)
Table 58. North America Nucleic Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Nucleic Vaccine Sales by Application (2024-2024) (K Units)
Table 60. Europe Nucleic Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Nucleic Vaccine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Nucleic Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Nucleic Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Nucleic Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Nucleic Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Nucleic Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Nucleic Vaccine Sales by Country (2024-2024) & (K Units)
Table 68. North America Nucleic Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Nucleic Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Nucleic Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Nucleic Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Nucleic Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Nucleic Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Nucleic Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Nucleic Vaccine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Nucleic Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Nucleic Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Nucleic Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Nucleic Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Nucleic Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Nucleic Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Nucleic Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Nucleic Vaccine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Nucleic Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Nucleic Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Nucleic Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Nucleic Vaccine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Nucleic Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Nucleic Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Nucleic Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Nucleic Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Nucleic Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Nucleic Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Nucleic Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Nucleic Vaccine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Nucleic Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Nucleic Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Nucleic Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Moderna Company Information
Table 108. Moderna Introduction and Business Overview
Table 109. Moderna Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Moderna Nucleic Vaccine Product
Table 111. Moderna Recent Development
Table 112. CureVac Company Information
Table 113. CureVac Introduction and Business Overview
Table 114. CureVac Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. CureVac Nucleic Vaccine Product
Table 116. CureVac Recent Development
Table 117. Inovio Company Information
Table 118. Inovio Introduction and Business Overview
Table 119. Inovio Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Inovio Nucleic Vaccine Product
Table 121. Inovio Recent Development
Table 122. Sanofi Company Information
Table 123. Sanofi Introduction and Business Overview
Table 124. Sanofi Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Sanofi Nucleic Vaccine Product
Table 126. Sanofi Recent Development
Table 127. GSK Company Information
Table 128. GSK Introduction and Business Overview
Table 129. GSK Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. GSK Nucleic Vaccine Product
Table 131. GSK Recent Development
Table 132. CNBG Company Information
Table 133. CNBG Introduction and Business Overview
Table 134. CNBG Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. CNBG Nucleic Vaccine Product
Table 136. CNBG Recent Development
Table 137. Hualan Bio Company Information
Table 138. Hualan Bio Introduction and Business Overview
Table 139. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Hualan Bio Nucleic Vaccine Product
Table 141. Hualan Bio Recent Development
Table 142. Zhifei Shengwu Company Information
Table 143. Zhifei Shengwu Introduction and Business Overview
Table 144. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Zhifei Shengwu Nucleic Vaccine Product
Table 146. Zhifei Shengwu Recent Development
Table 147. Liaoning Chengda Company Information
Table 148. Liaoning Chengda Introduction and Business Overview
Table 149. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Liaoning Chengda Nucleic Vaccine Product
Table 151. Liaoning Chengda Recent Development
Table 152. BioKangtai Company Information
Table 153. BioKangtai Introduction and Business Overview
Table 154. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. BioKangtai Nucleic Vaccine Product
Table 156. BioKangtai Recent Development
Table 157. CanSinoBIO Company Information
Table 158. CanSinoBIO Introduction and Business Overview
Table 159. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. CanSinoBIO Nucleic Vaccine Product
Table 161. CanSinoBIO Recent Development
Table 162. Walvax Biotechnology Company Information
Table 163. Walvax Biotechnology Introduction and Business Overview
Table 164. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Walvax Biotechnology Nucleic Vaccine Product
Table 166. Walvax Biotechnology Recent Development
Table 167. Fosun Pharma Company Information
Table 168. Fosun Pharma Introduction and Business Overview
Table 169. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Fosun Pharma Nucleic Vaccine Product
Table 171. Fosun Pharma Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Nucleic Vaccine Market Trends
Table 175. Nucleic Vaccine Market Drivers
Table 176. Nucleic Vaccine Market Challenges
Table 177. Nucleic Vaccine Market Restraints
Table 178. Nucleic Vaccine Distributors List
Table 179. Nucleic Vaccine Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Nucleic Vaccine Product Picture
Figure 2. Global Nucleic Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nucleic Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Nucleic Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Preventive Nucleic Vaccine
Figure 6. Global Preventive Nucleic Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Therapeutic Nucleic Vaccine
Figure 8. Global Therapeutic Nucleic Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Nucleic Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Nucleic Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Nucleic Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Nucleic Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Nucleic Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Nucleic Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Nucleic Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Nucleic Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Nucleic Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Vaccine Revenue in 2022
Figure 23. Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Nucleic Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Nucleic Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Nucleic Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Nucleic Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Nucleic Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Nucleic Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Nucleic Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Nucleic Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Nucleic Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Nucleic Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Nucleic Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Nucleic Vaccine Manufacturing Cost Structure
Figure 43. Nucleic Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries